PROCEPT BioRobotics Corporation Company Profile
NASDAQ: PRCTHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 7, 4:00 PM ET
PROCEPT BioRobotics at a glance
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is a Medical/Dental Instruments company in the Health Care sector headquartered in San Jose, CA. PROCEPT BioRobotics is led by Mr. Larry L. Wood and employs about 888 people. The company's shares have traded publicly since 2021.
At a market capitalization of $1.00 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001588978, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does PROCEPT BioRobotics do?
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Business description based on the company's public filings.
Company information
- Legal name
- PROCEPT BioRobotics Corporation
- Ticker
- NASDAQ: PRCT
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Larry L. Wood
- Employees
- 888
- Headquarters
- 150 Baytech Drive, San Jose, CA, United States
- Phone
- 650 232 7200
- Website
- procept-biorobotics.com
- IPO year
- 2021
- Market cap
- $1.00B
- SEC CIK
- 0001588978
Companies similar to PROCEPT BioRobotics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IARTIntegra LifeSciences Holdings Corporation | 13.00 | -2.40% | $1.01B | vs PRCT |
| BBNXBeta Bionics Inc. | 18.08 | -2.95% | $975.35M | vs PRCT |
| AORTArtivion Inc. | 21.61 | -1.05% | $1.05B | vs PRCT |
| TNDMTandem Diabetes Care Inc. | 15.57 | -1.70% | $1.08B | vs PRCT |
| IRMDiRadimed Corporation | 85.47 | +0.77% | $1.09B | vs PRCT |
| BVSBioventus Inc. Class A | 12.77 | -2.52% | $872.26M | vs PRCT |
| SIBNSI-BONE Inc. | 19.10 | -2.30% | $856.03M | vs PRCT |
| SGPSpyGlass Pharma Inc. | 23.90 | -3.55% | $799.41M | vs PRCT |